Oura’s strategic shift: from health tracker to medical-grade wearable with IPO ambitions

Oura has filed for a US listing amid a transformation from sleep and recovery tracking to a broader health and medical device provider, signalling a new era for its smart-ring technology and ambitions.

What looked in May like a product refresh tied to a confidential flotation plan has, by early September, become a clearer statement of what Oura is trying to be. The smart-ring maker publicly filed for a US listing on 3 September, saying it had sold 3.6 million rings in the 12 months to 30 June 2026, grown to 5.0 million paid members and lifted revenue to $1.21 billion in the first nine months of its 2026 financial year. It has applied to trade on Nasdaq under the symbol OURA. That is a material step on from the confidential IPO filing disclosed in May, when Oura was still presenting the move mainly as proof of momentum around its health ambitions. (medtechdive.com)

The hardware at the centre of that pitch is the Ring 5, unveiled on 28 May and shipped from 4 June. Oura priced it from £399 in the UK and $399 in the US, with Black and Silver as the entry models and four other finishes costing more. The company says the ring is 40% smaller than the previous generation; WIRED reported dimensions of 6.09 mm wide and 2.28 mm thick, alongside battery life of six to nine days. Oura and reviewers also point to stronger sensors, more powerful LEDs and an optional portable charging case intended to stretch battery life away from a cable. (techcrunch.com)

The more important change, however, is strategic rather than cosmetic. Oura is trying to move from sleep and recovery tracking into something closer to preventive health. MedTech Dive reported that the company’s October 2025 fundraising was tied to developing new medical features, while the Los Angeles Times said Oura was adding tools aimed at spotting possible signs of hypertension and sleep apnoea. Tom Hale, the chief executive, told the newspaper: “We think of ourselves as a healthcare company, not a tech company.” That ambition now includes a Resmed partnership around sleep assessment, Dexcom integration for over-the-counter glucose monitors, and an AI-assisted advisory layer expanded through Counsel Health. Oura’s own software framing matters here: these tools are presented as signals and prompts, not diagnoses. (medtechdive.com)

The public filing also makes the economics easier to read. Oura says membership was about 20% of revenue in the nine months to 30 June 2026, with hardware supplying the other 80%, but it also says the subscription is central to “unlocking the full value” of the ring. More than 94% of activations convert into paid membership after the trial period, according to the filing, and 12-month paid-member retention stood at about 85% as of 30 June. In other words, the ring is not being sold as a one-off gadget with optional extras attached; the recurring fee is integral to the model. (sec.gov)

That does not mean every health number deserves to be treated as a verdict. Engadget’s review found that some of Oura’s most eye-catching additions, including Health Radar, were not yet available to test in the UK at publication. It also noted that the blood-pressure feature does not measure blood pressure directly, but infers it from existing signals such as pulse wave velocity. In one example, the reviewer received a sleep score of 84 after a poor night during the UK heatwaves, but a readiness score of 56 because resting heart rate was up and heart-rate variability was down. The implication, and it is an inference from that testing, is that Oura may be more useful as a trend reader than as a judge of any single night. (engadget.com)

The same pattern appears in exercise tracking. Oura has improved the fitness side of the product with Live Activity, better automatic workout detection and support for third-party heart-rate monitors. TechCrunch reported that users can now start a session from the phone and watch pace, distance and other metrics in real time, while WIRED said those figures appear through lock-screen widgets and make the ring feel more capable during runs. But the phone remains the live display. That leaves Ring 5 in a narrower category than a sports watch: stronger than before for casual logging, still less persuasive for people who want training data on the move, and arguably less fitness-led than rivals such as Ultrahuman. (techcrunch.com)

Oura is making that bet in a market that is clearly growing, even if estimates differ on the pace. The Los Angeles Times, citing IDC, said smart-ring shipments rose by nearly 51% in 2025. The Guardian, using CCS Insight data, put the market at 4 million devices last year after more than doubling in each of the previous two years. Both accounts agree on the broad direction: Oura remains the best-known name in a young category, but it is no longer alone. TechCrunch pointed to pressure from RingConn and Ultrahuman, while Oura itself has expanded into markets including Japan and India in search of the next wave of growth. (latimes.com)

The result is a product that is easier to understand as a business than as a simple device purchase. Ring 5 is slimmer, more polished and, by most accounts, still the strongest smart ring in mainstream consumer technology. But Oura is really asking buyers to accept a broader proposition: continuous wear, continuous software and increasingly medical-sounding guidance, all tied to a continuing fee and to uneven regional roll-out of features. Investors are now being asked to back that model in public markets. Consumers, meanwhile, still have to decide whether they want discreet long-term context about sleep and recovery, or whether they are being sold a ring that promises more certainty than a wrist full of algorithms can reliably deliver. (latimes.com)